LVIS

LVIS Corporation is a technology company based in Palo Alto, California, founded in 2013. The company specializes in advanced neural information analysis to enhance neurological healthcare. Its flagship product, NeuroMatch®, is an AI-powered software platform that rapidly interprets EEG data, significantly improving patient throughput compared to traditional methods. NeuroMatch® features include artifact reduction, automated reporting, and secure, HIPAA-compliant data storage. LVIS supports healthcare providers and neurologists in addressing the increasing demand for neurological diagnostics and treatment, particularly for complex brain network disorders. The company holds exclusive licenses for patents from institutions like UCLA and Stanford and has a team of experts in neuroscience and bioengineering. In addition to software development, LVIS engages in joint ventures to create pharmaceutical and therapeutic candidates aimed at improving patient care. The company has been recognized for its innovative work through various programs and research grants.